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Purpose:  Multiple  studies  demonstrate  a  strong  association  between  three  variants  at  chromosome  10q26  –
rs10490924, del443ins54, and rs11200638 – near the age-related maculopathy susceptibility 2 (ARMS2) and high-
temperature requirement factor A1 (HTRA1) genes with susceptibility to age-related macular degeneration (AMD). In
different reports, the del443ins54 and rs11200638 variants are suggested to affect ARMS2 mRNA stability and/or
HTRA1 mRNA expression, respectively. The goal of this study is to examine whether these AMD-associated variants
alter expression levels of ARMS2 and HTRA1 in human retina samples.
Methods: Genomic DNA and total RNA were obtained from 35 human retinas (three young controls, average age=32
years; twenty aged controls, average age=72 years;  and twelve     AMD      retinas,  average age=7  7 years)  using   standard
procedures. As ARMS2 exhibits higher expression in the human placenta, we also included eighteen placenta samples in
our analysis. Four polymorphisms – rs2736911, rs10490924, del443ins54, and rs11200638 – were genotyped by PCR
followed by sequencing. Expression of ARMS2, HTRA1 and three endogenous control genes (rRNA [rRNA], hypoxanthine
phosphoribosyltransferase 1 [HPRT1], and glyceraldehyde-3-phosphate dehydrogenase [GAPDH]) was measured by real-
time quantitative RT–PCR using Taqman gene expression or SYBR Green assays.
Results: ARMS2 and HTRA1 mRNA levels did not show a significant difference in expression among the control (young
and elderly) and AMD retinas. No association of del443ins54 and rs11200638 variants was detected with mRNA
expression levels of ARMS2 or HTRA1 in the retina. Human placenta samples showed high variability in expression levels.
Conclusions: We did not find association between AMD susceptibility variants at 10q26 and steady-state expression
levels of either ARMS2 or HTRA1 in the human retina.
Age-related macular degeneration (AMD) is a prevalent
and complex disorder that primarily affects the central region
of the retina (macula) and is a leading cause of untreatable
visual impairment and legal blindness in older individuals
[1,2].  Early  stages  of  AMD  exhibit  pigmentary  and
morphological  changes  in  the  retinal  pigment  epithelium
(RPE). Large and soft drusen in the macula are identified as
strong risk factors for the development of advanced forms of
AMD,  which  include  central  geographic  atrophy  and
choroidal neovascularization [3-6]. Advanced age, inherited
susceptibility involving several genes, and environmental risk
factors are involved in the pathogenesis of AMD [6].
Genetic studies have demonstrated the contribution of
multiple susceptibility loci; variants on chromosomes 1q31
and  10q26  account  for  a  major  part  of  the  genetic
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susceptibility to AMD [6,7]. Several independent reports have
elucidated the importance of Y402H and multiple non-coding
variants  in  the  complement  factor  H  (CFH)  gene  on
chromosome  1q31  in  AMD  susceptibility  [8-13].  Single
nucleotide polymorphisms (SNPs) in three other complement
factor genes (C2/BF,C3, and CFI) are also associated with
susceptibility to AMD [14-17]. More recent genome wide
association studies have also implicated variants near tissue
inhibitor of metalloproteinase 3 (TIMP3) and several high
density  lipoprotein  (HDL)-associated  loci  in  AMD
susceptibility [18,19].
Outside  the  complement  pathway,  the  major  genetic
contributor to AMD susceptibility is the locus at 10q26. The
association  signals  center  over  two  neighboring  genes,
ARMS2 (age-related maculopathy susceptibility 2, previously
called LOC387715; OMIM +611313) [20,21] and HTRA1
(high-temperature  requirement  factor  A1;  OMIM  602194)
[22,23],  suggesting  two  plausible  candidates.  The  AMD-
associated SNP rs11200638 in the promoter of HTRA1 was
reported to result in increased expression levels of HTRA1
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1317mRNA and protein [22,23]. Our previous studies revealed that
the SNP rs10490924 in exon 1 of the ARMS2 gene is strongly
associated with AMD and that rs11200638 had no significant
impact  on  HTRA1  promoter  activity  in  various  cell  lines
[24].  Another  group  reported  an  insertion/deletion
polymorphism, NM_001099667.1: c.* 372_815del443ins54
in 3′-UTR of ARMS2, which is strongly associated with AMD;
this variant deletes the polyadenylation signal and inserts a
54-bp  AU-rich  element,  resulting  in  an  unstable  ARMS2
transcript (Figure 1A) [25]. As strong linkage disequilibrium
exists across the ARMS2/HTRA1 region, genetic studies are
likely  insufficient  to  distinguish  between  the  causal
association of two genes with AMD. More recently, one report
suggests  that  the  haplotype  carrying  del443ins54  and
rs11200638 affects HTRA1 expression; this study used in vitro
assays and RNA from human placenta samples [26]. Another
recent  report  shows  that  del443ins54  does  not  lead  to  a
decrease in the stability of ARMS2 mRNA in lymphocytes
[27]. We reasoned that human retina samples are necessary to
clarify the impact of AMD-associated 10q26 SNPs on the
biologic activity of ARMS2 and HTRA1 as reflected by their
steady-state mRNA levels. Here, we report the results of our
concurrent genotyping and qRT–PCR analyses of 35 retinas
and 18 placenta samples.
METHODS
Human tissues: Thirty-two retina tissues were collected from
Caucasian individuals less than 6 h post-mortem and obtained
from  the  National  Disease  Research  Interchange
(Philadelphia, PA), and three retina samples were from the
Age-Related Histopathology Laboratory at the University of
Alabama at Birmingham. Human placentas were obtained
from the Labor and Delivery floor at the Hospital University
of Pennsylvania within 4 h of delivery.
Genotyping: Nucleic acids (total RNA with genomic DNA)
were isolated from tissues using TRIzol (Invitrogen, Carlsbad,
CA).  A  part  of  the  sample  was  used  to  perform  PCR
amplifications with ExTaq (TaKaRa Bio USA, Madison, WI).
The PCR amplified DNA was sequenced directly according
to ABI BigDye terminator kit version 3.1 using ABI 3130xl
Genetic Analyzer (Applied Biosystems, Foster City, CA).
Primers for PCR amplification of 10q26 SNPs and sequencing
are Fwd 5′-CCT TTG TCA CCA CAT TAT GTC C-3′ and
Rev  5′-GCC  TGA  TCA  TCT  GCA  TTT  CTT  AC-3′  for
rs2736911 and rs10490924, Fwd 5′-ATC TGG ATT CCT
CTC TGT CAC TG-3′ and Rev 5′-AAT GAA GTC CAA GCT
TCT TAC CC-3′ for del443ins54, Fwd 5′-GAC GTG TGA
AGG ATT CTA TTC GAA-3′ and Rev 5′-GCG TCC TTC
AAA CTA ATG GAA CTT-3′ for rs11200638.
qRT–PCR analysis and statistical methods: We checked RNA
with gel and/or bioanalyzer. Reverse transcription (RT) was
performed with Superscript II (Invitrogen) and oligo dT(20)
primers per standard protocols [28]. Taqman gene expression
assays were purchased for HTRA1,GAPDH,HPRT1, and 18S
ribosomal (r)RNA and used on a 7900HT Fast Real-Time PCR
System  (Applied  Biosystems)  per  the  manufacturer’s
instructions.  SYBR  Green  PCR  Master  Mix  (Applied
Biosystems) was used for the ARMS2 expression assay. The
ARMS2 amplification primers were Fw 5′-GAT GGC AAG
TCT GTC CTC CT-3′ and Rv 5′-TTG CTG CAG TGT GGA
TGA  TAG-3′.  Real-Time  qRT–PCR  reactions  were
performed in quadruplicate. The relative quantification of the
target   transcript    was   performed   using   SDS2.0    and   RQ 
manager  software  (Applied Biosystems).   Gene expression 
levels  were calculated  using   the  2-ddCt  method   [29].  All 
experimental  sample were normalized using  human  rRNA 
as  an  internal  control.   rRNA  is a good internal control for 
gene expressionin retinas, and showed uniform values. Other 
internal    controls    also    showed    similar    results.    The 
significance  of the difference  with a  reference  experiment 
was    calculated    using       the    Student's    t-test,    ANOVA 
(ANOVA) and linear regression.
RESULTS
We  first  examined  whether  there  is  any  change  in  the
expression of ARMS2 and HTRA1 between normal aged and
AMD retinas without genotype constraints. The aged retinas
were  obtained  from  20  unrelated  individuals  (average
age=71.8 year), while the AMD group consisted of 12 retinas
(average age=77.1 year). Gene expression was measured by
real-time qRT–PCR and normalized to rRNA expression, with
aged normal retinas as a reference. There was no significant
difference in either ARMS2 or HTRA1 mRNA expression
levels  between  the  two  groups  (ARMS2,  fold  change
average=1.051,  p=0.487;  HTRA1,  fold  change
average=0.991,  p=0.918).  As  predicted,  the  housekeeping
genes (used as controls), HPRT1 and GAPDH, did not show
significant  change  in  expression  with  age  (fold  change
average=0.963,  p=0.376  and  fold  change  average=0.997,
p=0.934), validating a high quality of RNA from the human
retinas for qRT–PCR analysis.
To determine changes in RNA expression due to aging,
we compared the gene expressions of normal young (average
age=32.3 year, three retinas) and elderly (average age=75.5
year, six retinas) groups having common variants at all four
genotyped  loci  (rs2736911,  rs10490924,  del443ins54,  and
rs11200638);  no  significant  differences  were  obtained
(ARMS2, fold change average=0.944, p=0.719; HTRA1, fold
change  average=1.078,  p=0.634;  HPRT1  fold  change
average=0.987,  p=0.910  and  GAPDH  fold  change
average=0.974, p=0.778) (Figure 1B-E). Aged normal retinas
were taken as a reference in this comparison. Additionally, we
did not find any significant expression differences based on
gender within the aged retinas.
To assess the impact of rs11200638 on HTRA1 [23] and
of del443ins54 on ARMS2 mRNA [25], we determined the
genotypes  at  the  four  10q26  SNPs  and  measured  the
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1318Figure 1. Relationship of ARMS2 and HTRA1 expression in the human retina to the genotypes at 10q26. A: Schematic representation of
positions of polymorphic variants at chromosome 10q26. White boxes indicate exons and gray shows translated regions. Numbers indicate
the nucleotide position in NT_030059.12 (NCBI Reference Sequence). B-E: Gene expression in the human retina. We investigated the effect
of AMD-associated variants near ARMS2 and HTRA1 genes on expression levels of ARMS2 and HTRA1 in human retina samples. Fold changes
in expression of the target genes (ARMS2, HTRA1, HPRT1, and GAPDH) relative to the internal control gene (rRNA) were correlated to the
genotypes of four polymorphisms at 10q26. The samples were analyzed after qRT–PCR reactions performed in quadruplicate with Taqman
gene expression or SYBR Green assays. The fold change average in expression of the target gene was calculated using the 2-ddCt method;
ddCt=(Ct,Target - Ct,rRNA)experiment - (Ct,Target - Ct,rRNA)reference. Gene expressions in wild-type (with common variants at the four loci)
older normal retinas were used as a reference. Black unique symbols (e.g., triangle, square, diamond, dash, X’s cross, circle) indicate individual
sample changes, and white square shows the average. Abbreviations: Avg. represents average; N represents number of samples with a given
genotype; P represents polymorphism (P/P represents homozygous; P/- represents heterozygous change. Variants are in the left column).
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1319expression levels of ARMS2 and HTRA1 in all 35 retinas using
real-time qRT–PCR. First, we conducted general tests for all
samples to study the association between gene expression and
the four polymorphisms regardless of disease and age status.
ANOVA and linear regression were performed respectively
on  free  and  additive  models  for  genotypes.  There  is  no
significant gene expression difference (p>0.05). A similar
result was obtained for analysis in case or control group only.
Furthermore, we analyzed the expression data by stratifying
on  different  genotypes.  Heterozygous  rs10490924,
del443ins54, and rs11200638 did not affect the mRNA levels
of  ARMS2  and  HTRA1  genes  (ARMS2,  fold  change
average=0.989,  p=0.944;  HTRA1,  fold  change
average=0.985,  p=0.916).  No  expression  changes  were
detected  even  in  individuals  homozygous  for  these  SNPs
(ARMS2, fold change average=0.926, p=0.589; HTRA1, fold
change average=1.197, p=0.302; Figure 1B,C). Additionally,
retinas heterozygous or homozygous for the rs2736911 SNP
did not show a significant change in expression (heterozygote,
ARMS2, fold change average=1.046, p=0.785; HTRA1, fold
change average=1.184, p=0.435) (homozygote, ARMS2, fold
change=0.706; HTRA1, fold change=1.287; Figure 1B,C).
Although  our  results  for  homozygous  rs2736911  are
represented by only one retina, it does not appear to affect the
expression; this SNP causes nonsynonymous R38X alteration
in ARMS2 and it is not reportedly associated with AMD risk.
No significant differences in expression were observed for
HPRT1 and GAPDH (p>0.05; Figure 1D,E).
We then compared expression between six aged normal
and four AMD (age average=81.5 year) retinas that did not
carry the polymorphic variants at the four 10q26 loci tested.
ARMS2 and HTRA1 expression did not reveal a significant
difference  (ARMS2,  fold  change  average=0.970,  p=0.793;
HTRA1, fold change average=1.104, p=0.585; HPRT1, fold
change  average=0.924,  p=0.296;  GAPDH,  fold  change
average=0.929,  p=0.307;  Figure  1B-E).  Further  analysis
showed  no  significant  differences  in  HTRA1  and  ARMS2
expressions  in  AMD  retinas  that  were  heterozygous  for
rs10490924,  del443ins54,  and  rs11200638  (ARMS2,  fold
change  average=0.943,  p=0.771;  HTRA1,  fold  change
average=0.953,  p=0.769),  and  heterozygous  rs2736911
(ARMS2, fold change average=1.133, p=0.383; HTRA1, fold
change average=1.084, p=0.685) compared to normal retinas
with the common alleles (Figure 1B,C). While there was only
one  AMD  retina  homozygous  for  del443ins54  or
rs11200638, the expression levels exhibited no appreciable
change  from  normal  retinas  (ARMS2,  fold  change=1.001;
HTRA1, fold change=1.084). HPRT1 and GAPDH expression
in these retinas did not reveal a significant difference (p>0.05;
Figure 1D,E). We also evaluated the expression of ARMS2
and HTRA1 in human placentas. However, the expression
levels of these two genes demonstrated wide variations that
could  not  be  explained  by  their  genotype  (Figure  2A,B).
Interestingly,  the  two  housekeeping  genes  (HPRT1  and
GAPDH) did not manifest the large variations in expressions
observed for ARMS2 or HTRA1 (Figure 2C,D).
DISCUSSION
Gene expression changes have been investigated in multiple
species and scenarios to study the genetic basis of variations
in gene regulation [30-32]. The binding of transcriptional
factors to a specific sequence constitutes a key aspect of gene
regulation. Other means of regulating gene expression include
DNA methylation, alternative splicing, and mRNA stability
[33]. Genetic variations (DNA polymorphisms) are known to
be associated with phenotypic variation and may alter gene
expression patterns [34].
A genetic locus at chromosome 10q26 provides strong
susceptibility  to  AMD;  specifically,  two  AMD-associated
polymorphisms near ARMS2 and HTRA1 genes have been
suggested to alter the gene expression of either one or the other
gene  [23,25,26].  The  investigations  of  associated
polymorphisms and their impact on expression levels have
been elusive and contradictory. To examine this issue further
and in the context of aging and AMD retinas, we concurrently
obtained genotypes of human normal and AMD retinas and
examined whether specific haplotypes or polymorphisms at
10q26 might be correlated to steady-state transcript levels of
ARMS2  or  HTRA1.  In  our  study,  none  of  the  four
polymorphisms  (rs2736911,rs10490924,  del443ins54,  and
rs11200638) either as homozygotes or heterozygotes or their
associated haplotypes significantly affected the ARMS2 or
HTRA1 gene expression levels. One study recently reported
that haplotypes with del443ins54 and rs11200638 variants
have an effect on HTRA1 and ARMS2 expression in genotyped
human placentas [26]. However, another report presented that
the  del443ins54  variant  does  not  change  ARMS2  mRNA
stability in lymphocytes [27], which is consistent with our data
from retina samples. In our study, ARMS2 and HTRA1 gene
expression levels in the placentas exhibited wider variations
than in retinas, thus making it difficult to draw a definitive
conclusion.  While  all  our  retinas  were  collected  from
Caucasian subjects, no ethnic information was available for
our placenta samples. The wide variations in ARMS2 and
HTRA1 may be a reflection of ethnic differences; curiously
however, the housekeeping genes (HPRT1 and GAPDH) did
not exhibit such differences in expression. The two previous
studies examined the effects of del443ins54 and rs11200638
variants  in  transfected  human  embryonic  kidney  cells  or
transfected  mouse  RPE  [25,26];  however,  there  is  a  poor
homology in the human and mouse DNA sequence about 13kb
upstream from the HTRA1 transcriptional start site, and the
ARMS2 gene, including del443ins54, is primate specific. We
suggest  that  ARMS2  and  HTRA1  mRNA  expression  and
stability are regulated via distinct mechanisms in the retina
compared  to  other  tissues.  It  should  be  noted  that  the
del443ins54 variant sequences in our samples are similar to
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1320those reported previously [25,35], and no additional changes
are identified as reported recently [27].
Interestingly, ARMS2 and HTRA1 expression levels in a
single  human  retina  sample  that  is  homozygous  for  the
ARMS2-R38X variant (rs2736911) are similar to those of
other  genotypes.  This  variant  is  predicted  to  produce  a
truncated  ARMS2  protein.  We  must  note  that  AMD  is  a
multifactorial disease with numerous susceptibility loci [18];
therefore, the altered ARMS2 expression or function alone
will not be sufficient to cause AMD. The ARMS2 gene exists
only in primates but not in other vertebrates, thus it is unlikely
to have an essential or critical role in retinal physiology. We
hypothesize that ARMS2 has a unique supportive function in
photoreceptors and/or retinal pigment epithelium of primates.
In  conclusion,  our  studies  do  not  support  the  direct
association  between  the  genotype  of  rs11200638  and
Figure 2. Relationship of ARMS2 and HTRA1 expression in the human placenta to the genotypes at 10q26. We show the effect of AMD-
associated variants near ARMS2 and HTRA1 genes on ARMS2 and HTRA1 expression in human placenta samples. A-D: The fold change in
expression of the target genes (ARMS2, HTRA1, HPRT1, and GAPDH) relative to the internal control gene (rRNA) were correlated to genotypes
of corresponding placenta samples. Real-time qRT–PCR reactions were performed in quadruplicate with Taqman gene expression or SYBR
Green assays. The fold change average in the expression of the target gene was calculated using the 2-ddCt method; ddCt=(Ct,Target -
Ct,rRNA)experiment - (Ct,Target - Ct,rRNA)reference. Gene expressions in wild-type (having common variants at all four genotyped loci) placentas
were used as a reference. cBlack unique symbols (e.g., triangle, square, diamond, dash, X’s cross, circle) indicate individual sample changes,
and white square shows the average. Abbreviations: N represents number of samples with given genotypes; P represents polymorphism (P/P
represents homozygous; P/- represents heterozygous change. Variants are shown in the left column).
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1321HTRA1 mRNA levels, and between the del443ins54 variant
and ARMS2 mRNA levels in human retina samples we have
analyzed. We suggest that comprehensive investigations at the
protein and function levels, not only the protein expression,
will be necessary to further clarify the roles of ARMS2 and/
or HTRA1 in AMD etiology. Such studies will require well
characterized and specific antibodies for ARMS2 and HTRA1
and investigations with human (or primate) tissues/samples
carrying distinct AMD-associated genotypes.
ACKNOWLEDGMENTS
We thank Matthew Brooks, Tiziana Cogliati and members of
the Swaroop laboratory for advice and comments. This work
was  supported  by  intramural  funds  and  grants  from  the
National Eye Institute, The Foundation Fighting Blindness,
and  Research  to  Prevent  Blindness.  Also,  this  work  was
supported from International Retinal Research Foundation
(C.C.).
REFERENCES
1. Sarks SH. Ageing and degeneration in the macular region: a
clinico-pathological  study.  Br  J  Ophthalmol  1976;
60:324-41. [PMID: 952802]
2. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular
degeneration.  N  Engl  J  Med  2000;  342:483-92.  [PMID:
10675430]
3. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G,
Davis  MD,  de  Jong  PT,  Klaver  CC,  Klein  BE,  Klein  R,
Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR,
Vingerling  JR,  The  International  ARM  Epidemiological
study  group.  An  international  classification  and  grading
system for age-related maculopathy and age-related macular
degeneration.  Surv  Ophthalmol  1995;  39:367-74.  [PMID:
7604360]
4. de Jong PT. Age-related macular degeneration. N Engl J Med
2006; 355:1474-85. [PMID: 17021323]
5. Zarbin MA. Current concepts in the pathogenesis of age-related
macular  degeneration.  Arch  Ophthalmol  2004;
122:598-614. [PMID: 15078679]
6. Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling
a multifactorial late-onset disease: from genetic susceptibility
to disease mechanisms for age-related macular degeneration.
Annu Rev Genomics Hum Genet 2009; 10:19-43. [PMID:
19405847]
7. Fisher SA, Abecasis GR, Yashar BM, Zareparsi S, Swaroop A,
Iyengar SK, Klein BE, Klein R, Lee KE, Majewski J, Schultz
DW,  Klein  ML,  Seddon  JM,  Santangelo  SL,  Weeks  DE,
Conley YP, Mah TS, Schmidt S, Haines JL, Pericak-Vance
MA, Gorin MB, Schulz HL, Pardi F, Lewis CM, Weber BH.
Meta-analysis  of  genome  scans  of  age-related  macular
degeneration. Hum Mol Genet 2005; 14:2257-64. [PMID:
15987700]
8. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C,
Farrer LA. Complement factor H polymorphism and age-
related  macular  degeneration.  Science  2005;  308:421-4.
[PMID: 15761121]
9. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber
AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD,
Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC,
Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC,
Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold
B,  Dean  M,  Allikmets  R.  A  common  haplotype  in  the
complement  regulatory  gene  factor  H  (HF1/CFH)
predisposes individuals to age-related macular degeneration.
Proc  Natl  Acad  Sci  USA  2005;  102:7227-32.  [PMID:
15870199]
10. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM,
Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR,
Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance
MA. Complement factor H variant increases the risk of age-
related  macular  degeneration.  Science  2005;  308:419-21.
[PMID: 15761120]
11. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C,
Henning  AK,  SanGiovanni  JP,  Mane  SM,  Mayne  ST,
Bracken  MB,  Ferris  FL,  Ott  J,  Barnstable  C,  Hoh  J.
Complement factor H polymorphism in age-related macular
degeneration. Science 2005; 308:385-9. [PMID: 15761122]
12. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T,
Chakravarthy U. A common CFH haplotype, with deletion of
CFHR1 and CFHR3, is associated with lower risk of age-
related macular degeneration. Nat Genet 2006; 38:1173-7.
[PMID: 16998489]
13. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R,
Wade MS, Li Y, Liang L, Zareparsi S, Swaroop A, Abecasis
GR. CFH haplotypes without the Y402H coding variant show
strong association with susceptibility to age-related macular
degeneration.  Nat  Genet  2006;  38:1049-54.  [PMID:
16936733]
14. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs
K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT,
Hageman GS, Dean M, Allikmets R. Variation in factor B
(BF) and complement component 2 (C2) genes is associated
with  age-related  macular  degeneration.  Nat  Genet  2006;
38:458-62. [PMID: 16518403]
15. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly
MJ, Seddon JM. Common variation in three genes, including
a noncoding variant in CFH, strongly influences risk of age-
related macular degeneration. Nat Genet 2006; 38:1055-9.
[PMID: 16936732]
16. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid
H,  Clayton  DG,  Hayward  C,  Morgan  J,  Wright  AF,
Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC,
Moore AT. Complement C3 variant and the risk of age-related
macular  degeneration.  N  Engl  J  Med  2007;  357:553-61.
[PMID: 17634448]
17. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ,
Seddon JM. Variation near complement factor I is associated
with  risk  of  advanced  AMD.  Eur  J  Hum  Genet  2009;
17:100-4. [PMID: 18685559]
18. Chen W, Stambolian D, Edwards AO, Branham KE, Othman
M,  Jakobsdottir  J,  Tosakulwong  N,  Pericak-Vance  MA,
Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A,
Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK,
Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M,
Baratz KH, Brown WL, Group CR, Brucker AJ, Orlinn A,
Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B,
Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BEK,
Gotoh N, Yamashiro K, Ferris F, Fagerness JA, Reynolds R,
Molecular Vision 2010; 16:1317-1323 <http://www.molvis.org/molvis/v16/a145> © 2010 Molecular Vision
1322Farrer LA, Kim IK, Miller JW, Cortón M, Carracedo A,
Sanchez-Salorio  M,  Pugh  EW,  Doheny  KF,  Brion  M,
DeAngelis MM, Week DE, Zack D, Chew EY, Heckenlively
JR,  Yoshimura  N,  Iyengar  SK,  Francish  PJ,  Katsanis  N,
Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A.
Genetic  Variants  near  TIMP3  and  HDL-Associated  Loci
Influence  Susceptibility  to  Age-Related  Macular
Degeneration. Proc Natl Acad Sci USA 2010; 107:7401-6.
[PMID: 20385819]
19. Neale  BM,  Fagerness  J,  Reynolds  R,  Sobrin  L,  Parker  M,
Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E,
Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA Jr,
Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S,
Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ,
Seddon JM. Genome-wide association study of advanced age-
related macular degeneration identifies a role of the hepatic
lipase  gene  (LIPC).  Proc  Natl  Acad  Sci  USA  2010;
107:7395-400. [PMID: 20385826]
20. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE,
Gorin MB. Susceptibility genes for age-related maculopathy
on  chromosome  10q26.  Am  J  Hum  Genet  2005;
77:389-407. [PMID: 16080115]
21. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P,
Meitinger  T,  Weber  BH.  Hypothetical  LOC387715  is  a
second  major  susceptibility  gene  for  age-related  macular
degeneration,  contributing  independently  of  complement
factor H to disease risk. Hum Mol Genet 2005; 14:3227-36.
[PMID: 16174643]
22. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam
PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP,
Hoh J. HTRA1 promoter polymorphism in wet age-related
macular degeneration. Science 2006; 314:989-92. [PMID:
17053108]
23. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen
H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J,
Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K,
Zhang  K.  A  variant  of  the  HTRA1  gene  increases
susceptibility to age-related macular degeneration. Science
2006; 314:992-3. [PMID: 17053109]
24. Kanda  A,  Chen  W,  Othman  M,  Branham  KE,  Brooks  M,
Khanna R, He S, Lyons R, Abecasis GR, Swaroop A. A
variant of mitochondrial protein LOC387715/ ARMS2, not
HTRA1,  is  strongly  associated  with  age-related  macular
degeneration.  Proc  Natl  Acad  Sci  USA  2007;
104:16227-32. [PMID: 17884985]
25. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A,
Keilhauer CN, Weber BH. Age-related macular degeneration
is associated with an unstable ARMS2 (LOC387715) mRNA.
Nat Genet 2008; 40:892-6. [PMID: 18511946]
26. Yang Z, Tong Z, Chen Y, Zeng J, Lu F, Sun X, Zhao C, Wang
K, Davey L, Chen H, London N, Muramatsu D, Salasar F,
Carmona R, Kasuga D, Wang X, Bedell M, Dixie M, Zhao P,
Yang R, Gibbs D, Liu X, Li Y, Li C, Li Y, Campochiaro B,
Constantine  R,  Zack  DJ,  Campochiaro  P,  Fu  Y,  Li  DY,
Katsanis N, Zhang K. Genetic and functional dissection of
HTRA1  and  LOC387715  in  age-related  macular
degeneration.  PLoS  Genet  2010;  6:e1000836.  [PMID:
20140183]
27. Wang G, Spencer KL, Scott WK, Whitehead P, Court BL,
Ayala-Haedo J, Mayo P, Schwartz SG, Kovach JL, Gallins P,
Polk M, Agarwal A, Postel EA, Haines JL, Pericak-Vance
MA. Analysis of the indel at the ARMS2 3′UTR in age-related
macular  degeneration.  Hum  Genet  2010;  127:595-602.
[PMID: 20182747]
28. Sambrook J, Russell DW. Molecular Cloning, A Laboratory
Manual,  Third  Edition.  New  York:  Cold  Spring  Harbor
Laboratory Press; 2001.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta
C(T)). Method. Methods. 2001; 25:402-8.
30. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo
V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao
M, Stoughton RB, Friend SH. Genetics of gene expression
surveyed  in  maize,  mouse  and  man.  Nature  2003;
422:297-302. [PMID: 12646919]
31. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M,
Burdick JT. Mapping determinants of human gene expression
by  regional  and  genome-wide  association.  Nature  2005;
437:1365-9. [PMID: 16251966]
32. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch
S,  Lyle  R,  Hunt  S,  Kahl  B,  Antonarakis  SE,  Tavare  S,
Deloukas P, Dermitzakis ET. Genome-wide associations of
gene  expression  variation  in  humans.  PLoS  Genet  2005;
1:e78. [PMID: 16362079]
33. Wray  GA.  Transcriptional  regulation  and  the  evolution  of
development.  Int  J  Dev  Biol  2003;  47:675-84.  [PMID:
14756343]
34. Pastinen T, Ge B, Hudson TJ. Influence of human genome
polymorphism on gene expression. Hum Mol Genet 2006;
15:R9-16. [PMID: 16651375]
35. Gotoh  N,  Nakanishi  H,  Hayashi  H,  Yamada  R,  Otani  A,
Tsujikawa A, Yamashiro K, Tamura H, Saito M, Saito K, Iida
T, Matsuda F, Yoshimura N. ARMS2 (LOC387715) variants
in  Japanese  patients  with  exudative  age-related  macular
degeneration and polypoidal choroidal vasculopathy. Am J
Ophthalmol 2009; 147:1037-41. [PMID: 19268887]
Molecular Vision 2010; 16:1317-1323 <http://www.molvis.org/molvis/v16/a145> © 2010 Molecular Vision
The print version of this article was created on 10 July 2010. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1323